Article citationsMore>>

García-Grimshaw, M., Michel-Chávez, A., Vera-Zertuche, J.M., Galnares-Olalde, J.A., Hernández-Vanegas, L.E., et al. (2021) Guillain-Barré Syndrome Is Infrequent among Recipients of the BNT162b2 mRNA COVID-19 Vaccine. Clinical Immunology, 230, Article ID: 108818.
https://doi.org/10.1016/j.clim.2021.108818

has been cited by the following article:

• TITLE: COVID-19 Infection Presenting as Myalgia, Abnormal Liver Function Tests and the Guillain-Barre Syndrome

  AUTHORS: Senyo Tagboto

  KEYWORDS: Guillain-Barre Syndrome, COVID-19, Myalgia

  JOURNAL NAME: Advances in Infectious Diseases, Vol.12 No.1, March 11, 2022

  ABSTRACT: The severe acute respiratory syndrome coronavirus 2 infection typically presents with respiratory symptoms. Additionally, there are a number of less frequent neurological manifestations of infection with the coronavirus disease 2019 (COVID-19) with case reports suggesting an association with the Guillain-Barre syndrome. Most patients present with the typical upper respiratory symptoms in association with these neurological symptoms. We present a case of an unvaccinated gentleman with none of the typical respiratory symptoms of COVID-19 who presented with the Guillain Barre syndrome and myalgia. His symptoms settled following treatment with intravenous immunoglobulins. This case highlights the importance of testing for COVID-19 in patients without typical symptoms but who present with neurological illness and supports the use of intravenous immunoglobulin therapy.